Nagaya and co-workers identified higher expression of the CXC chemokine signaling genes, including CXCL1, CXCL3, CXCL6, CXCR1 and CXCR2 in prostate cancer bone metastases [51]. This evidence concerns the gene CXCL1 and prostate cancer.